<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>16</volume><submitter>Klimov-Kravtchenko K</submitter><pubmed_abstract>Alterations in gut microbiota composition have been implicated in various diseases, including cancer. Recent evidence suggests that intestinal microbiota may influence the efficacy of immunotherapy. In this study, we investigated the relationship between gut dysbiosis and NK cell exhaustion in Mexican patients with cervical cancer (CC), a connection not previously explored. This cross-sectional study included newly diagnosed CC patients, a separate cohort of post-radio-chemotherapy (RCT) patients, and healthy donors (HD). Fecal microbiota profiles were assessed using 16S rRNA sequencing, while peripheral NK cell immune checkpoint expression was analyzed by multiparametric flow cytometry. CC patients exhibited significant gut dysbiosis, marked by reduced α-diversity, enrichment of pro-infla</pubmed_abstract><journal>Frontiers in immunology</journal><pagination>1637098</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12615445</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Microbiota-immune dysregulation in cervical cancer patients from Western Mexico: linking gut dysbiosis and NK cell exhaustion as promising biomarkers.</pubmed_title><pmcid>PMC12615445</pmcid><pubmed_authors>Solorzano-Ibarra F</pubmed_authors><pubmed_authors>Baltazar-Diaz TA</pubmed_authors><pubmed_authors>Castano-Jimenez PA</pubmed_authors><pubmed_authors>Facundo-Medina CG</pubmed_authors><pubmed_authors>Del Toro-Arreola S</pubmed_authors><pubmed_authors>Bueno-Topete MR</pubmed_authors><pubmed_authors>Rojas-Diaz JM</pubmed_authors><pubmed_authors>Haramati J</pubmed_authors><pubmed_authors>Klimov-Kravtchenko K</pubmed_authors><pubmed_authors>Garcia-Barrientos NT</pubmed_authors><pubmed_authors>Cruz-Ramos JA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Microbiota-immune dysregulation in cervical cancer patients from Western Mexico: linking gut dysbiosis and NK cell exhaustion as promising biomarkers.</name><description>Alterations in gut microbiota composition have been implicated in various diseases, including cancer. Recent evidence suggests that intestinal microbiota may influence the efficacy of immunotherapy. In this study, we investigated the relationship between gut dysbiosis and NK cell exhaustion in Mexican patients with cervical cancer (CC), a connection not previously explored. This cross-sectional study included newly diagnosed CC patients, a separate cohort of post-radio-chemotherapy (RCT) patients, and healthy donors (HD). Fecal microbiota profiles were assessed using 16S rRNA sequencing, while peripheral NK cell immune checkpoint expression was analyzed by multiparametric flow cytometry. CC patients exhibited significant gut dysbiosis, marked by reduced α-diversity, enrichment of pro-infla</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025</publication><modification>2026-06-05T16:24:39.956Z</modification><creation>2026-06-05T03:06:33.162Z</creation></dates><accession>S-EPMC12615445</accession><cross_references><pubmed>41246357</pubmed><doi>10.3389/fimmu.2025.1637098</doi></cross_references></HashMap>